Original Source(s)
Related Content
FDA Approves Baxdrostat for Resistant Hypertension
Phase 3 findings support the oral therapy in adults with persistent blood pressure elevation despite multidrug treatment.
May 18, 2026
-
2 min
Top 10 FDA Recalls Physicians Should Know
A structured overview of recent FDA recalls, corrections, and alerts involving medications, ventilators, insulin delivery systems, cardiovascular devices, anesthesia products, and other equipment used in clinical practice.
June 18, 2026
-
5 min
Mild Hyponatremia After TJA: Safe to Discharge?
Associations with medical and overall complications were largely driven by acute kidney injury in a retrospective single-center study
May 6, 2026
-
4 min